Skip to main content

What's new

Medicare has updated its policy to now accept the inhaled insulin Afrezza, as well as injected insulin options to count towards the multiple daily administrations of insulin requirement for glucose monitoring systems coverage. Continue Reading »

For decades, researchers have sought to develop a noninvasive method to measure blood glucose levels, which – if effective – could revolutionize diabetes care. One company in Israel now has such a device in development. Learn about the origins of this technology, its early success, and what this could mean for people with diabetes. Continue Reading »

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the largest conference in diabetes, including automated insulin delivery, continuous glucose monitoring, extremely promising drugs in development, and more. Continue Reading »

The American Diabetes Association’s 81st Scientific Sessions is going strong. Updates from days two and three include promising Omnipod 5 results, Medtronic’s seven-day infusion set, and Control-IQ real-world data. Continue Reading »

We bring you the most exciting news from day one of the 81st ADA Scientific sessions, including updates on inhaled insulin, digital diabetes management programs, automated insulin delivery, beta cell replacement therapies, and more. Continue Reading »

Nick Jonas, singer, actor, and advocate for people with diabetes, is launching The Global Movement for Time in Range, an educational ad campaign to raise awareness for Time in Range in partnership with Beyond Type 1, other diabetes nonprofits, and Dexcom. Learn about Nick’s experience with Time in Range and why he is launching this initiative now. Continue Reading »

A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The study will evaluate the use of automated insulin delivery in young children to see if it improves Time in Range and other health metrics. Continue Reading »

The latest innovations in diabetes technology have brought Time in Range (TIR) to the forefront of diabetes care. Read to learn about the most exciting TIR news from one of the biggest international diabetes conferences of the year, with a special focus on automated insulin delivery systems for kids, adults, and seniors. Continue Reading »

Pages